Publications

0
Total Number of Publications
0
Number of Publications this Year
0
Number of Publications last Month
Displaying 2291 results out of a total of 2291 publications.

Filter publications:

Search publications:

The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8(+)T Cell Anti-tumor Activity
Kleijn, A;van den Bossche, W;Haefner, ES;Belcaid, Z;Burghoorn-Maas, C;Kloezeman, JJ;Pas, SD;Leenstra, S;Debets, R;de Vrij, J;Dirven, CMF;Lamfers, MLM;
Mol Ther Oncolytics, Mol Ther Oncolytics, 5():11-19, 2018
View publication
The tumor suppressor phosphatase PP2A-B56? regulates stemness and promotes the initiation of malignancies in a novel murine model
Janghorban, M;Langer, EM;Wang, X;Zachman, D;Daniel, CJ;Hooper, J;Fleming, WH;Agarwal, A;Sears, RC;
PLoS ONE, PLoS ONE, 12(11):e0188910, 2018
View publication
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression
Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, et al
Cell Death Differ, 18(7):1174–83, 2011
View publication
Optimized Culture System to Induce Neurite Outgrowth From Retinal Ganglion Cells in Three-Dimensional Retinal Aggregates Differentiated From Mouse and Human Embryonic Stem Cells
Maekawa et al
Curr Eye Res, [Epub ahead of print], 2015, 2015
View publication
MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation
Yang, Qinbo et al
International Journal of Cardiology, [Epub ahead of print], 2014
View publication
Genomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal Differentiation in Glioblastoma Cells
Tamim S, Vo DT, Uren PJ, Qiao M, Bindewald E, Kasprzak WK, et al
PLoS One, 9(1):e85591, 2014
View publication
Abstract B12: Co-targeting PTEN-defined TNBC with p110beta-isoform specific inhibitor and PARP inhibitor BMN 673: A predictive context to sensitize PARP inhibitors
Dey, N;Carlson, JH;De, P;Leyland-Jones, B;
Molecular Cancer Research, Mol Cancer ResFebruary 201614;B12, 2016
View publication
Targeting the podocyte to treat glomerular kidney disease
Lal MA,Young KW,Andag U,
Drug Discov. Today, pii: S1359-6446(15)00233-0, 2015

Researchers at AstraZeneca and Evotec use IncuCyte™ to functionally validate and assess the potency of screening hits in an ex vivo model of diabetic nephropathy revealing novel opportunities for kidney-specific therapeutics.

View publication
A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice
Waaler J, Machon O, Tumova L, Dinh H, Korinek V, Wilson SR, et al
Cancer Res, 72(11):2822–32, 2012
View publication
Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex
Park, SY;Yoon, S;Sun, EG;Zhou, R;Bae, JA;Seo, YW;Chae, JI;Paik, MJ;Ha, HH;Kim, H;Kim, KK;
Int J Mol Sci, Int J Mol Sci, 18(12):, 2018
View publication
1 2 3 4 5 6 7 8 9 10 11 12 ...
No file selected
0%
Stay up-to-date with what's happening at Essen BioScience

© 2019 Essen BioScience

Privacy Policy